Morgan Stanley on Zai Lab (ZLAB) Post BMY (BMY) Approval: 'We believe it should bode moderately positively for ZLAB shares'
Go back to Morgan Stanley on Zai Lab (ZLAB) Post BMY (BMY) Approval: 'We believe it should bode moderately positively for ZLAB shares'| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 64.65 +0.95 (1.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $63.70 | 52 Week High | $77.12 | |||
| Open | $64.05 | 52 Week Low | $49.03 | |||
| Day High | $65.02 | P/E | 41.98 | |||
| Day Low | $63.91 | EPS | $1.54 | |||
| Volume | 10,526,026 | |||||
| (NASDAQ: ZLAB) | Delayed: 26.03 +0.54 (2.12%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $25.49 | 52 Week High | $ | |||
| Open | $26.21 | 52 Week Low | $ | |||
| Day High | $26.38 | P/E | N/A | |||
| Day Low | $25.70 | EPS | $ | |||
| Volume | 1,042,217 | |||||
